The unique asymmetric bevel of NANOPASS cuts the skin instead of puncturing it. This decreases the resistance while penetrating the skin* – designed to reduce pain.
* Intra company data
The special thin pen needle size of only 32.5G (0.22 mm) causes less skin trauma than larger needle sizes.
The large inner diameter of NANOPASS 32.5 optimizes the insulin flow for an easy insulin injection.
Nanopass®32.5G is not sold in North America.
Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.
The device has no components made of natural rubber latex.